Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.65 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.55 |
| ▸ | ATM | Q13315 | 2/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.49 |
| ▸ | CA2 | P00918 | 3/20 | 0.49 |
| ▸ | LMNA | P02545 | 3/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.48 |
| ▸ | RECQL | P46063 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.43 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.43 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.43 |
| ▸ | HCAR2 | Q8TDS4 | 2/20 | 0.40 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.40 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5547265 | 0.94 | TSHR (0.57) | TSHRCYP3A4TDP1ATMALDH1A1 | |
| SCHEMBL87501 | 0.90 | TSHR (0.77) | TSHRCYP3A4TDP1ATMALDH1A1 | |
| SCHEMBL226708 | 0.90 | TSHR (0.77) | TSHRCYP3A4TDP1ATMALDH1A1 | |
| SCHEMBL423544 | 0.90 | TSHR (0.77) | TSHRCYP3A4TDP1ATMALDH1A1 | |
| Butane SCHEMBL10783052 | 0.89 | TSHR (0.75) | TSHRCYP3A4TDP1ATMALDH1A1 | |
| SCHEMBL19529571 | 0.87 | TSHR (0.73) | TSHRCYP3A4TDP1ATMALDH1A1 | |
| SCHEMBL10530524 | 0.87 | TSHR (0.45) | TSHRCYP3A4TDP1ATMALDH1A1 | |
| SCHEMBL29288070 | 0.85 | TSHR (0.71) | TSHRCYP3A4TDP1ATMALDH1A1 | |
| SCHEMBL22115517 | 0.85 | TSHR (0.71) | TSHRCYP3A4TDP1ATMALDH1A1 | |
| SCHEMBL818398 | 0.85 | TSHR (0.71) | TSHRCYP3A4TDP1ATMALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 467 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4717744-A1 | USE OF A COMPOSITION BASED ON CYANOACRYLATE AND (METH)ACRYLATE | Bostik SA (FR) | 2026-04-01 | — | — | EP | claimed |
| EP-3852815-B1 | STABLE COMPOSITIONS COMPOSED OF A RADIOPAQUE AGENT AND CYANOACRYLATE MONOMER AND APPLICATIONS THEREOF | CHEMENCE MEDICAL INC (US) | 2026-02-25 | — | — | EP | claimed |
| US-20250215132-A1 | TWO-PART CURABLE COMPOSITION | BOSTIK SA (FR) | 2025-07-03 | — | — | US | claimed |
| US-20240240064-A1 | TWO-PART CURABLE COMPOSITION | BOSTIK SA (FR) | 2024-07-18 | — | — | US | claimed |
| EP-4334368-A1 | TWO-PART CURABLE COMPOSITION | Bostik SA (FR) | 2024-03-13 | — | — | EP | claimed |
| CN-117377706-A | Two-part curable composition | 博斯蒂克股份公司 | 2024-01-09 | — | — | CN | claimed |
| EP-4274628-A1 | CATHETER SECUREMENT COMPOSITIONS AND METHODS | Adhezion Biomedical, LLC (US) | 2023-11-15 | — | — | EP | claimed |
| CN-117062636-A | Catheter securement compositions and methods | 艾德合森生物医药有限责任公司 | 2023-11-14 | — | — | CN | claimed |
| WO-2023194367-A1 | TWO-PART CURABLE COMPOSITION | BOSTIK SA (FR) | 2023-10-12 | — | — | WO | claimed |
| EP-4257648-A1 | TWO-PART CURABLE COMPOSITION | Bostik SA (FR) | 2023-10-11 | — | — | EP | claimed |
| US-6420590-B1 | STRIPPING SOLVENT FROM POLYCYANOACRYLATE, CRACKING AND DISTILLATION | CLOSURE MEDICAL CORPORATION | 2002-07-16 | — | — | US | claimed |
| WO-2002036549-A2 | CONTINUOUS PROCESSES AND APPARATUS FOR FORMING CYANOACETATE AND CYANOACRYLATE | CLOSURE MEDICAL CORPORATION (US) | 2002-05-10 | — | — | WO | claimed |
| US-20020018752-A1 | Polymerizable compositions and methods of use | STRYKER EUROPEAN HOLDINGS III, LLC | 2002-02-14 | — | — | US | claimed |
| WO-2001089501-A1 | POLYMERIZABLE COMPOSITIONS AND METHODS OF USE | PROVASIS THERAPEUTICS, INC. (US) | 2001-11-29 | — | — | WO | claimed |
| EP-0886507-A4 | MONOMERIC COMPOSITIONS EFFECTIVE AS WOUND CLOSURE DEVICES | CLOSURE MEDICAL CORP (US) | 2001-11-28 | — | — | EP | claimed |
| US-6245933-B1 | CONDENSING A CYANOACETATE WITH PARAFORMALDEHYDE OR FORMALDEHYDE, REACTING THE POLYMER FORMED WITH AN ALCOHOL, AND DEPOLYMERIZING THE POLYMER TO FORM ALPHA-CYANOACRYLATE MONOMERS | CLOSURE MEDICAL CORPORATION | 2001-06-12 | — | — | US | claimed |
| WO-2001036380-A2 | TRANSESTERIFICATION METHOD FOR MAKING CYANOACRYLATES | CLOSURE MEDICAL CORPORATION (US) | 2001-05-25 | — | — | WO | claimed |
| US-5981621-A | COMPRISING AT LEAST ONE MONOMER, WHICH FORMS A MEDICALLY ACCEPTABLE POLYMER, AT LEAST ONE PLASTICIZING AGENT, AT LEAST ONE ACIDIC STABILIZING AGENT, AN INITIATOR | CLOSURE MEDICAL CORPORATION (US) | 1999-11-09 | — | — | US | claimed |
| EP-0886507-A1 | MONOMERIC COMPOSITIONS EFFECTIVE AS WOUND CLOSURE DEVICES | Closure Medical Corporation (US) | 1998-12-30 | — | — | EP | claimed |
| WO-1997031598-A1 | MONOMERIC COMPOSITIONS EFFECTIVE AS WOUND CLOSURE DEVICES | CLOSURE MEDICAL CORPORATION (US) | 1997-09-04 | — | — | WO | claimed |